A clear example of a preclinical GEMM that has provided mechanistic insight into therapy response and resistance of BRCA1‐mutated breast cancer is the K14cre;Brca1F/F;Trp53F/F (KB1P) mouse model. Here, BRCA1 is linked to breast carcinoma.